Maybe if I spoke to them as often as you imagine I do.
Those articles are both new and I haven’t spoken to Steph for weeks.
FWIW I don’t think any company ‘wants’ to be asked questions but I am grateful they are trying multiple avenues to communicate despite the occasional cynicism. I think it’s been a good effort with about 3 domestic investor trips, 1 or 2 international ones, the quarterly phone hook ups, the online interviews, research reports, written news stories and now an avenue for Q&A in here. If they land a deal I am certain there are a lot more people watching nowdays and I suspect that through these efforts there are already a number of potential sources of capital if they need it and given the recent pattern of ‘placements’ at premiums in the bio space I hope PYC can achieve something similar now the SP has drifted. With the MACD having crossed a week ago any move above this 3-3.2c level should see 4-5c again pretty quickly. We seem to have run out of supply of shares for now.
![]()
- Forums
- ASX - By Stock
- PYC
- Questions for Phylogica
PYC
pyc therapeutics limited
Add to My Watchlist
1.56%
!
$1.27

Questions for Phylogica, page-19
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.27 |
Change
-0.020(1.56%) |
Mkt cap ! $737.8M |
Open | High | Low | Value | Volume |
$1.29 | $1.29 | $1.25 | $4.616M | 3.649M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 19940 | $1.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.27 | 1008 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 19940 | 1.250 |
2 | 4225 | 1.225 |
1 | 20000 | 1.220 |
1 | 4000 | 1.200 |
1 | 8000 | 1.135 |
Price($) | Vol. | No. |
---|---|---|
1.265 | 1008 | 1 |
1.270 | 6262 | 1 |
1.285 | 58876 | 2 |
1.295 | 24500 | 1 |
1.300 | 28670 | 3 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online